Company / CapEx per Share
Cogent Biosciences, Inc. CapEx per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.01 / $0.12
FY2021-FY2025
Trend
+118.5%
vs FY2024
Sector context
#115 of 190
Health Care
What the data says
At $0.01, Cogent Biosciences, Inc.'s capex per share ranks #115 of 190 in the Health Care sector. CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $0.01.
Based on SEC 10-K filings.
0.01 in FY2025 with a 3-year CAGR of -53.1%.
Declined from $0.04 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -53.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#115 of 190 in Health CareTop 61% of 190This company $0.01 Sector average $2.49
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 118.5% year-over-year.
- Ranks #115 out of 190 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +118.5% |
| FY2024 | $0.01 | -84.3% |
| FY2023 | $0.04 | -70.0% |
| FY2022 | $0.12 | +163.2% |
| FY2021 | $0.04 | - |
| FY2020 | - | - |
| FY2019 | $0.00 | -80.4% |
| FY2018 | $0.02 | -75.4% |
| FY2017 | $0.09 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026